Pfizer waxay heshiis $ 43bn ah la gashay hal-abuuraha dawada kansarka Seagen

13″ March”2023

Shirkadda weyn ee dawooyinka ee Pfizer ayaa heshiis $43bn ah la gashay shirkadda bayotechnoolajiyadda ee Seagen si ay ugu darto daawayn cusub oo lala beegsaday boggeeda daawaynta kansarka.

Heshiiska isniinta ayaa ah kii ugu weynaa ee Pfizer ee iibsasho xiriir ah ka dib markii dabaylo lacag ah ay ka dhacday tallaalkeeda COVID-19 iyo kaniinkeeda. Soo iibsigu wuxuu ku dari doonaa afar daawaynta kansarka oo la ansixiyay oo leh iibka la isku daray ku dhawaad ​​$2bn sanadka 202

Pfizer ayaa Isniintii sheegtay inay bixin doonto $229 oo caddaan ah saami kasta oo Seagen ah. Waxa ay markaa qorshaynaysaa in ay u ogolaato soosaaraha dawada bayotechnoolajiyada “inuu sii wado hal-abuurnimada” marka laga reebo ilo ka badan inta uu keligii yeelan lahaa, Gudoomiyaha Pfizer iyo Maamulaha Guud Albert Bourla ayaa u sheegay falanqeeyayaasha.

Bothell, Seagen fadhigeedu yahay Washington wuxuu ku takhasusay la shaqaynta isku-xidhka daroogada ee antibody, ama ADC, tignoolajiyada. Alaabooyinkeeda muhiimka ah waxay isticmaalaan borotiinada shaybaadhka lagu sameeyo ee loo yaqaanno monoclonal antibodies kuwaas oo raadiya unugyada kansarka si ay uga caawiyaan bixinta daawada kansarka dila iyada oo la ilaalinayo unugyada ku wareegsan.

Daawaynta kansarku waa mudnaanta Pfizer. Waxay u keeneen $12bn dakhliga soo gala daroogada sameeya sannadkii hore. Laakiin Pfizer waxa ay suuq geysay kaliya lamaane jiilkii koowaad ee daawaynta ADC, afhayeen ayaa tiri

Seagen waxay leedahay afar daawayn oo suuqa ah. Waxa kale oo ay leedahay dhuumo dawooyin ah oo horumarsan kuwaas oo ay ku jiraan daawaynta suurtagalka ah ee nooc ka mid ah kansarka sanbabada iyo kansarka naasaha ee horumarsan.

“Waxaan u maleyneynaa in tani ay runtii si weyn u beddesho joogitaanka Oncology ee Pfizer, oo ka dhigaysa mid nooc ka mid ah,” Bourla ayaa tiri.

Iibiyaha sare ee Seagen, Adcetris, wuxuu daaweeyaa kansarka nidaamka lymfa. Waxay lahayd $839m iibka sannadkii hore, korodhka 19 boqolkiiba sannadkii hore.

Seagen wuxuu kaloo heshiis la leeyahay Pfizer’s Array BioPharma si uu u horumariyo, ugana iibiyo daawaynta kansarka naasaha iyo mindhicirka Tukysa. Waxay u keentay $353m iibka Seagen sannadkii hore

Shirkadda, oo magaceeda ka beddeshay Seattle Genetics 2020, waxay aragtay wadarta dakhliga koray qiyaastii 25 boqolkiiba sannadkii hore ilaa ku dhawaad ​​$2bn. Seagen ayaa sidoo kale xiirtay khasaaraheeda ilaa $610m marka loo eego $674m sanadka 2021.

Horumarinta daawada Kansarka ayaa saadaalisay qiyaastii $2.2bn iibka sanadkan

Pfizer waxay ballansatay $100bn wadarta dakhliga sannadkii hore waxaana lagu shubay lacag caddaan ah iyada oo ay uga mahadcelinayaan iibinta tallaalkeeda COVID-19 Comirnaty iyo daawaynta Paxlovid.

Bourla ayaa sheegtay sanadkan in shirkadu ay qorshaynayso in ay u isticmaasho “awooddeeda dab-demiska ee aan caadiga ahayn” si ay u soo iibsato alaab keeni doonta $25bn dakhli korodh ah marka la gaadho 2030ka.

Heshiiska ayaa lagu dhawaaqay Isniintii iyo qaar ka mid ah iibsigii hore ayaa ka caawin doona Pfizer xisaabinta inta badan. Laakiin Bourla waxay ku nuuxnuuxsatay Isniintii in shirkaddu ay rajaynayso tabarucaadka Seagen in uu sii dheeraado dhamaadka tobanka sano.

Pfizer oo fadhigeedu yahay New York ayaa horeba $11.6bn ugu kharash garaysay horumarinta daawaynta dhanjafka ee Biohaven Pharmaceutical. Waxa kale oo ay $5.4bn ku bixisay daawaynta cudurka unugga sickle-ka ee samaysa Global Blood Therapeutics waxayna ku iibsatay Arena Pharmaceuticals $6.7bn oo kale.

Daroogadu waxay u baahan tahay ilo dakhli oo badan qayb ahaan sababtoo ah waxay wajaheysaa dhicitaanka shatiyada ilaalinta daawooyinka sida daaweynta kansarka naasaha Ibrance oo ka socda tartan jaban sanadaha soo socda

Pfizer ayaa sheegtay Isniintii in ay bixin doonto Seagen inta badan iyada oo loo marayo $ 31bn deyn cusub, oo waqti dheer ah.

Labada guddi ee labada shirkadood ayaa si wadajir ah u ansixiyay heshiiska. Laakiin xeer-ilaaliyeyaashu wali waxay u baahan yihiin inay eegaan, iyo saamilayda Seagen waa inay ansixiyaan.

Shirkaduhu waxay filayaan inay dhammaystiraan wax kala iibsiga dhammaadka 2023 ama horraanta 2024.

Saamiyada Pfizer ayaa kor u kacay 2 boqolkiiba ilaa $40.26 ka dib markii suuqyadu furmeen Isniintii halka kaydka Seagen uu kor u kacay in ka badan 15 boqolkiiba ilaa ku dhawaad ​​$200. Tusmooyinka waaweyn ayaa kor u yara kacay.

SOURCE: NEWS AGENCIES

Leave a Reply